The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Myeloma of the central nervous system: association with high‐risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations
Open accessAbstract
Summary. Involvement of the central nervous system (CNS) by multiple myeloma, as defined by the detection of malignant plasma cells in the cerebrospinal fluid in the presence of suggestive symptoms, is considered extremely rare. We report on the characteristics of 18 such patients diagnosed and treated at the University of Arkansas over the last 10 years for an overall incidence of approximately 1%. Their evaluation revealed association of CNS involvement with unfavourable cytogenetic abnormalities (especially translocations and deletion of the chromosome 13), high tumour mass, plasmablastic morphology, additional extramedullary myeloma manifestations and circulating plasma cells. The presence of these features should alert clinicians to the possibility of CNS involvement. The outcome of these patients was extremely poor despite the use of aggressive local and systemic treatment including autologous stem cell transplants. Given this universally poor prognosis, the application of allogeneic transplants should be studied in this clinical setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575 · cited 11×
“Of the 14 patients who survived for more than 2 weeks after the involvement of CNS was documented, the CSF cleared in £ 2 weeks after initiation of treatment in eight patients, in 2–4 weeks in four patients, while the remaining two patients died without ever having cleared their CSF. Systemic treatment was administere…”
MethodSelf-citation
Cited by
Multiple Myeloma: Clinical Review and Diagnostic Imaging
Angtuaco, E. J. C., Fassas, A. B. T., Walker, R., Sethi, R., & Barlogie, B. (2004) · Radiology · doi:10.1148/radiol.2311020452 · Cited by 299
Self-citationCentral nervous system myelomatosis: review of the literature
Nieuwenhuizen, L., & Biesma, D. H. (2008) · European Journal of Haematology · doi:10.1111/j.1600-0609.2007.00956.x · Cited by 147
Extramedullary disease in plasma cell myeloma: the iceberg phenomenon
Wirk, B., Wingard, J. R., & Moreb, J. S. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.26 · Cited by 49
Metadata
- Authors
- Fassas, A. B. ‐., Muwalla, F., Berryman, T., Benramdane, R., Joseph, L., Anaissie, E., Sethi, R., Desikan, R., Siegel, D., Badros, A., Toor, A., Zangari, M., Morris, C., Angtuaco, E., Mathew, S., Wilson, C., Hough, A., Harik, S., Barlogie, B., & Tricot, G.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2002-03-25
- Volume
- 117
- Issue
- 1
- Pages
- 103-108
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2094451192
- Cited by
- 167
- References
- 1
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.